Wall Street analysts forecast that RTI Surgical, Inc. (NASDAQ:RTIX) will post $69.83 million in sales for the current fiscal quarter, Zacks reports. Two analysts have made estimates for RTI Surgical’s earnings. The lowest sales estimate is $69.50 million and the highest is $70.16 million. RTI Surgical reported sales of $67.62 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 3.3%. The company is expected to report its next quarterly earnings report before the market opens on Tuesday, August 8th.

According to Zacks, analysts expect that RTI Surgical will report full year sales of $69.83 million for the current year, with estimates ranging from $281.20 million to $283.06 million. For the next fiscal year, analysts forecast that the business will post sales of $294.60 million per share, with estimates ranging from $293.30 million to $295.90 million. Zacks Investment Research’s sales averages are an average based on a survey of research analysts that cover RTI Surgical.

Several equities research analysts have commented on RTIX shares. Zacks Investment Research cut shares of RTI Surgical from a “hold” rating to a “sell” rating in a research report on Wednesday, May 3rd. TheStreet upgraded shares of RTI Surgical from a “d+” rating to a “c-” rating in a research report on Friday, May 5th. ValuEngine upgraded shares of RTI Surgical from a “sell” rating to a “hold” rating in a research report on Friday, June 2nd. Finally, BidaskClub cut shares of RTI Surgical from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 25th.

In related news, CEO Camille Farhat acquired 61,693 shares of the business’s stock in a transaction on Thursday, May 18th. The shares were purchased at an average price of $4.65 per share, for a total transaction of $286,872.45. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 4.90% of the stock is currently owned by insiders.

Hedge funds have recently bought and sold shares of the company. Victory Capital Management Inc. increased its stake in RTI Surgical by 1.1% in the second quarter. Victory Capital Management Inc. now owns 220,569 shares of the medical equipment provider’s stock valued at $1,290,000 after buying an additional 2,295 shares during the last quarter. Federated Investors Inc. PA increased its stake in RTI Surgical by 16.3% in the second quarter. Federated Investors Inc. PA now owns 43,245 shares of the medical equipment provider’s stock valued at $253,000 after buying an additional 6,065 shares during the last quarter. Wedge Capital Management L L P NC bought a new stake in RTI Surgical during the second quarter valued at about $1,471,000. Cigna Investments Inc. New bought a new stake in RTI Surgical during the second quarter valued at about $105,000. Finally, IFP Advisors Inc increased its stake in RTI Surgical by 35.1% in the second quarter. IFP Advisors Inc now owns 197,296 shares of the medical equipment provider’s stock valued at $1,154,000 after buying an additional 51,296 shares during the last quarter. Hedge funds and other institutional investors own 68.53% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “RTI Surgical, Inc. (RTIX) Expected to Post Quarterly Sales of $69.83 Million” was published by Daily Political and is the property of of Daily Political. If you are accessing this report on another domain, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The correct version of this report can be read at https://www.dailypolitical.com/2017/08/07/rti-surgical-inc-rtix-expected-to-post-quarterly-sales-of-69-83-million.html.

RTI Surgical (NASDAQ RTIX) traded down 1.79% during midday trading on Friday, hitting $5.50. 213,544 shares of the company’s stock traded hands. The company has a 50 day moving average of $5.60 and a 200-day moving average of $4.40. RTI Surgical has a 52 week low of $2.50 and a 52 week high of $6.00. The company’s market capitalization is $319.69 million.

RTI Surgical Company Profile

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Get a free copy of the Zacks research report on RTI Surgical (RTIX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.